Results 121 to 130 of about 48,932 (217)

Biomarker‐Based Diagnosis and Care Pathways for Alzheimer's Disease in the Era of Disease‐Modifying Treatments: A Consensus Statement by Belgian Experts

open access: yesEuropean Journal of Neurology, Volume 33, Issue 8, August 2026.
ABSTRACT Background The recent approval of disease‐modifying therapies (DMTs) for early Alzheimer's disease (AD) marks a major shift in clinical practice. Biomarker confirmation of amyloid pathology is now required alongside clinical assessment, and blood‐based tests are improving accessibility.
Tim Van Langenhove   +31 more
wiley   +1 more source

Neurofibrillary tangles predict dementia in patients with carotid stenosis. [PDF]

open access: yesJ Vasc Surg
Zahra S   +9 more
europepmc   +1 more source

NDRG2 Expression Correlates with Neurofibrillary Tangles and Microglial Pathology in the Ageing Brain. [PDF]

open access: yesInt J Mol Sci, 2020
Fadul MM   +8 more
europepmc   +1 more source

Neuropathological Evidence of Reduced Amyloid Beta and Neurofibrillary Tangles in Multiple Sclerosis Cortex. [PDF]

open access: yesAnn Neurol
Pansieri J   +8 more
europepmc   +1 more source

Outcome of resveratrol and resveratrol with donepezil combination on the β-amyloid plaques and neurofibrillary tangles in Alzheimer's disease. [PDF]

open access: yes3 Biotech
Rao YL   +9 more
europepmc   +1 more source

Neurofibrillary tangle-rich ganglioglioma [PDF]

open access: yesClinical Neuropathology, 2016
Ellen Gelpi   +6 more
openaire   +1 more source

Corrigendum: Genetic Background Influences the Propagation of Tau Pathology in Transgenic Rodent Models of Tauopathy

open access: yesFrontiers in Aging Neuroscience, 2020
Tomas Smolek   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy